Similarly, in metabolic disorders such as diabetes and obesity, genetic predispositions influence drug metabolism, insulin sensitivity, and lipid regulation, necessitating precision-based interventions to optimize therapeutic responses and prevent disease progression [2]. The gene discussed is INS; the disease is diabetes mellitus.